# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Chronic granulomatous disease, x-linked

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 20 results.
Gene Therapy for X-linked Chronic Granulomatous Disease
Status: Recruiting
Last Changed: May 30, 2018
First Received: May 02, 2016
Disease(s): X-Linked Chronic Granulomatous Disease
Intervention(s): X vivo gene therapy
Locations: Hôpital Necker Enfants Malades, Paris, France
Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD)
Status: Recruiting
Last Changed: Apr 15, 2019
First Received: May 16, 2013
Disease(s): X-Linked Chronic Granulomatous Disease
Intervention(s): X vivo gene therapy
Locations: University Hospital Frankfurt and Institute for Biomedical Research, Georg-Speyer-Haus, Frankfurt, Germany
University Children's Hospital Zürich, Zurich, Switzerland
University College London Hospital (UCLH), London, United Kingdom
Royal Free Hospital (RFH), London, United Kingdom
Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom
... and 1 other locations.
Gene Therapy for X-CGD
Status: Recruiting
Last Changed: Aug 02, 2013
First Received: Jul 24, 2013
Disease(s): X-linked Chronic Granulomatous Disease
Intervention(s): ex-vivo gene-therapy
Locations: University Hospital Frankfurt, Frankfurt am Main, Germany
Use of G-CSF to Obtain Blood Cell Precursors
Status: Recruiting
Last Changed: Nov 11, 2019
First Received: Nov 04, 1999
Disease(s): Granuloma, Granulomatous Disease, Chronic, Leukocyte Disease, Genetic Disease, X-Linked, Genetic Disease, Inborn
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease
Status: Recruiting
Last Changed: Jun 24, 2019
First Received: Jun 07, 2018
Disease(s): Chronic Granulomatous Disease
Intervention(s): Interferon Gamma-1B
Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
Status: Recruiting
Last Changed: Nov 05, 2019
First Received: Apr 10, 2019
Disease(s): Chronic Granulomatous Disease
Intervention(s): Busulfan, Alemtuzumab, Cyclophosphamide, Sirolimus, Total Body Irradiation, Allogeneic peripheral blood stem cell
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
Status: Recruiting
Last Changed: Sep 23, 2019
First Received: Apr 17, 2014
Disease(s): Chronic Granulomatous Disease
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
Status: Recruiting
Last Changed: Nov 08, 2019
First Received: Dec 14, 2015
Disease(s): Chronic Granulomatous Disease Transplant
Intervention(s): Campath, Busulfan IV, Sirolimus, cyclophosphamide
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous Disease
Status: Recruiting
Last Changed: Oct 25, 2019
First Received: May 10, 2013
Disease(s): Chronic Granulomatous Diseases (CGD) and Liver Lesions
Intervention(s): Cool-tip RF Ablation System
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Lentiviral Gene Therapy for CGD
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Aug 24, 2018
Disease(s): Chronic Granulomatous Disease
Intervention(s): Infusion of lentiviral TYF-CGD-modified autologous stem cells
Locations: Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China